newsfilter
← Latest News
ACCESS Newswire·

Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market

COSM
  • Cosmos Health Inc. (NASDAQ: COSM) engaged Prime Ledger to structure a non-dilutive, asset-specific tokenized financing for the CCX0722 medical device program without issuing common stock.
  • CCX0722 is an ingestible hydrogel-based medical device in development for weight management that uses a mechanical mechanism to expand over 100-fold in the stomach for satiety support with no systemic absorption.
  • The company holds full ownership of the technology via international patent application WO2025108566A1, with filings advanced into the United States, Europe, Australia, and Canada.
  • This financing positions Cosmos Health among the earliest NASDAQ-listed healthcare companies to pursue tokenized intellectual property-backed assets.
  • Prime Ledger will advise on valuation, asset mapping, regulatory pathway analysis, investor segmentation, and the legal entity structure for the offering.
  • The proposed structure aims to fund CCX0722's development while allowing Cosmos Health to retain all economic benefits and future cash flows from the asset.
  • The global weight management market is projected to reach $562.2 billion by 2033, while the broader tokenized real-world-asset market is projected to reach $18.9 trillion by 2033.
  • Cosmos Health and Prime Ledger target completion of the initial structuring phase in the fourth quarter of 2026.
  • Specific terms regarding the offering size, structure, jurisdictions, or distribution have not yet been determined.